2020년 11월 10일 화요일

[Note] Daily update tip from the specialty. (There is no rocket science !!! Just do it)

 GI bleeding

- PPI X2

- Octreotide 100

- Rectal exam !!!


Endocrinology DM1

- Pt. needs to be AAOX3 and know how to use it ! 

- continue power order + check the machine setting. 

- consult (for next day in AM)


2020년 7월 10일 금요일

[Q for NOTE] August 2020

8/17/20
# LVAD parameter algorithm
# SVT and ischemic workup
# CP vs Aortic dissection
 - workup - needs to be updated
 - d-dimer with sudden onset !!! and score system. 

Possible physical examination findings include the following:

  • Hypertension
  • Hypotension
  • Interarm blood pressure differential greater than 20 mm Hg
  • Signs of aortic regurgitation (eg, bounding pulses, wide pulse pressure, diastolic murmurs)
  • Findings suggestive of cardiac tamponade (eg, muffled heart sounds, hypotension, pulsus paradoxus, jugular venous distention, Kussmaul sign)
  • Neurologic deficits (eg, syncope, altered mental status)
  • Peripheral paresthesias
  • Horner syndrome
  • New diastolic murmur
  • Asymmetrical pulses (eg, carotid, brachial, femoral)
  • Progression or development of bruits


8/16/2020
# How to manage syncope vs POTS vs orthostatic ? 

# Amiodarone loading indication and protocol for VT managment

# premedication prior to cath (prednisone) 

# prep for GI workup(colonoscopy; esp. bisacodyl? suppository?)

# Stress test indication, choice, protocol and adverse event! 

# hyperammonemia? 


8/16/2020
# which stress test you should put in?
- indication
- contraindication
- pros vs cons

# COVID myocarditis management? 

# Nicotine patch in inpatient vs outpatient?
(How are you going to help them to surcease smoking) 
- Chantiks
- DNRI
- Nicotine patch, gum, and so on. 
- Actual plan book 

# Pre-Anticoagulation on ACS patient

# T-loading, S-loading 
-Medication half life, QT prolongation 3 HR
-EKG: calculation method, interval
-Contraindication
-How to approach if there is adverse event such as torsa de pointes?

# CMR

# ICD placement after ACS, indication

8/10/2020

# Aortitis Dx(DDx -cause) Tx Px 

# HIT Dx Tx Px

# Thyroid storm Tx Px

# Aspiration PNA - cause

# Sinus tachycardia

Ao. dissection protocol
 emergent

 urgent

 possible


DM meds
 insulin
 PO meds
 how often to f/u
 and parameter to work on


Anemia meds and f/u
 IV
 PO
 how often to f/u
 treatment goal and f.u

Hyperkalemia (tx. indication)
 Cardiac stablizing
 K lowering(transient and ultimate)

Gout
 initial regimen and workup
 recurrent gout management

CXR reading(medmastery)
USG reading(POCUS CHEST)

HTN emergency
 medication CTx. and Regimen
 scenario book - response - goal

AC in ACS
 heparin
 bivalirudin
 what else
 DOAC related issue
 contraindication in thrombocytopenia

LC
 evaluation
 p/ex.
 lab

P/Ex
 cardiac text make
 point - clinical meaningful movement.
 CXR/USG/RHC - clinical meaningful point.
 



2020년 4월 11일 토요일

[Diary] 05/27/2020

1. Contents => Chapter in textbook, +a @NOTE
2. NOTE(any topics ... need to be in file) 

3. Resource(1pg-file, large file in G-drive)

4/10/2020 - ? Myocarditis, Pericarditis
4/11/2020 - Y check(1400-1600). Plan => Chapter(follows textbook)

[ ] CV, PS for Fellowship one.
[ ]  LoR for Rao / Others (1 month ahead) 
[ ]  Prep. for Interview
[ ] M.S. Salva/Justin

[ ] Data collection to resources folder(2-3 weeks) after Reading Simple Book
    (Washington Manual, Cardiology Simple Book/QnA book; summary one)
 - uptodate essential QnA 

[ ] Review data for 2-3 days
 - Filing(Contents) 
  => Key project on 2020 ( 6 months left.  do it !! for sure) 
- and Book check
   - Cardiology: text book(for coming year!)
   - IM: Harrison's(later)

[ ] Summarize it for 2-3 hours

5/27
- Pneumonia

2020년 4월 4일 토요일

[NOTE] 112420. Save patient daily !!!

Metabolic alkalosis - EMCrit Project

1. Medmastery(https://www.medmastery.com/course-library) (pts@gamil; D.g-g)
2. POCUS (COURSE) https://accp.iccuelearning.com/ (pts@gmail - iccu) 
3. https://meded.ucsd.edu/clinicalmed/heart.htm#observation ; best physical exam guideline.
aa
Daily 10-11 reading and making YOUTUBE video from IT !! 

CONTENTS (all topic coverage; daily update as
[] (none or resource) -> [1] (1pg summary) ; should be saved in File/WORD file as well(to read in the future) 
=======================================ASSIGNMENT PUT IN CALENDAR

 -> [N] (Note) -> [V] (deep learning with book)]
=======================================DAILY UPDATE


Dermatology
 [1 ] Intertrigo


IM
[] Liver cirrhosis


[N] Warfarin adjustment(maintenance)

Endocrinology
[] Hyperglycemia on HD patient. (renal patient) 
[ ] Hyperglycemia(uncontrolled DM) 
[ ] Glucose control periprocedural. 
[ ] SGLP2 inhibitor
    vs 
    PCSK9 inhibitor
    vs
    PDE 5 inhibitors
= like new meds...
 indication
 dose
 follow up(continue? or temporarily)
 and adverse/contraindication

Hematology
[] Warfarin reversal 
 - INR >1.5 s/p Vitamin K 2.5mg 
[ ] Anemia
 [ ] IDA
 [ ] Thalassemia
 [N] CDI(C.diff infection) 

[1] Fungemia - fungal infection
 [ ] yeast infection (candidemia)
 [ ] other fungus

[] Contact precaution Ix. 
 - diarrhea
 - open wound

[] dysautonomia
 - dx. and tx. and px. 

[] Definition/Ix. of OT / PT
 OT: help to recover skills for daily living and working. therapeutic use of everyday activities (occupations). 
 children with disabilities; for social situations, injury rehabilitation,
 older adults; support physical and cognitive changes.
 PT: 
  

Cardiology
[ ] hypertensive crisis
 - urgency
 - emergency

[N] Cardiac catheterization related complication: bleeding


[N] OHT rejection.(cardiac transplant acute rejection) with infection(respiratory) combination

[N] OHT rejection.(cardiac transplant acute rejection)

[] CCB intoxication:
   BB intoxication: 

[] Hypomagnesemia:

[] Evolution of STEMI(EKG change)
[] RV STEMI
[] hypotension 
 - ix. of midodrine

[1] Resuscitation from WORD file(MEDMASTERY saved) 
 - 
[N] Myocarditis
[1] Myopericarditis
[ ] pericarditis

[] Aortic dissection

[N] Infectious endocarditis
ID
-Parasitology
[N] Bedbugs
[N] Lice

 [ ] 
[ ] obstructive -> cardiac arrest situation(ACLS etiology) such as PE(can be brady? only tachy?), stroke, MI, etc. with heart rate 

[ ] Lab: troponin I/T & CKMB 
[ ] Lab: BNP(entresto) vs NT proBNP
[ ] Lab: P2Y12 assay(plavix)
[ ] Lab: Transfusion labs for RBC, Platelet, Plasma or Neutropenia management.

[ICU book -> []1p and note]  Pulmonary catheter

=======================================================================

[] CABG PREP
Choosing antiplatelet therapy before during and after hosp for acs



Septic arthritis synoivial joint study 

f/u Rt. shoulder joint aspiration fluid analysis:
-Opaque, yellow colored aspiration
-Nucleated cell count(WBC): 58500
-PMN: 93%
-gram stain, culture: pending
-Crystal: negative
=> Inflammatory joint disease likely 2/2 Septic arthritis

# Suspicious septic arthritis:(Rt. shoulder)
- Still c/o shoulder pain.
- VSS, improving leukocytosis for now.
- Further image: CT upper extremity. 
- resume empirical antibiotics: vancomycin and Cefepime in setting of chronic immunosuppressed therapy related to Sarcoidosis. 
- NPO for possible washout.
- Will f/u ortho rec.
- d/w'd Dr. Rao


[ ] 
LVAD note:
 - LOW PI: vasodilatation <=> however SEPSIS with high circ = high PI


Trouble-shooting power abnormalities (e.g. for HEARTMATE II) — note that pump speed (rpm) will remain constant unless there is a suction event:

  • low power with low pulsatility index and steady pump speed
    • causes: inflow/ outflow obstruction, LV failure, dysrhythmia, hypertension
  • low power with normal or high pulsatility index
    • suckdown
  • high power with low pulsatility index fluctuating pump speed
    • pump thrombosis, vasodilation, hypotension, initial response to exercise
  • high power with high pulsatility index
    • normal physiological response to increased demand; myocardial recovery; fluid retention

Echocardiography findings

  • small RV suggests inadequate preload
  • small LV suggests suckdown
  • large RV and small LV suggests RV failure or pulmonary hypertension
  • large RV and large LV suggests pump thrombosis/ obstruction

LVAD ROS: 
Denies lightheadedness, syncope, palpitation
Denies: weakness, numbness, tingling
Denies: Dark urine, blood in urine, nosebleeds, stools
Denies: LVAD alarms, driveline fractures


physical exam
Doppler BP 88
MAP _
Vascular:  Nonpulsatile radial arteries. 

GEN: NAD, moderately obese, BMI 36
HEENT: NC/AT, sclera anicteric, pupils equal and round, oropharynx moist
Neck: supple, no thyromegaly, _no JVD at _90 degree incline
RESP: b/l air entry, no wheezing, _no crackles, normal respiratory effort
CV: sternotomy well healed, stable sternum, normal hum of continuous flow VAD, _no pitting edema
GI/Abd: soft, not tender; driveline site without tenderness, erythema or discharge
SKIN: no rash, no bruising
MS: no joint effusions, normal muscle bulk, normal strength
Neuro: AAOx3, no focal deficits
Psych: normal mood, appropriate affect, cooperative
LVAD: no driveline fractures, no evidence of equipment dysfunction


LVAD Interrogation:
speed 2980,
flow 4.9, 
power 5.7, 
pulsatility  7/4
No alarms.
Normal device function.
Hematocrit:  33
Alarms settings:  High power 8.5 w, low flow 2.0 L/min

[] lactic acidosis(lactic acidosis)
 DDx

Complete List


[ ] Stroke evaluation by NEUROLOGY
(SUBACUTE -> NO URGENCY) 
CT head
CTA head and neck
MRI without contrast
TTE

-MRI without contrast to evaluate size of stroke, pt on heparin ggt, but may be at risk for hemorrhagic transformation
-TTE with bubble study with Definity to rule out thrombus or intracardiac vegetations given mechanical heart valve, PFO
-EKG NSR, LVH noted
-Telemetry monitoring
-INR was 2.4
-DVT noted, pt on therapeutic heparin ggt
-LDL goal <70, A1C goal <6.5, levels pending
-BP goal <220/120 for first 24 hrs, then normotensive BP goal



[] AMS
Plan 
Recommend infectious and metabolic workup for acute encephalopathy 
Recommending obtaining brain MRI  without contrast to further assess for ischemic process
At this time, can resume AC for atrial fibrillation 
Please perform bedside swallow exam, if patient fails or has signs of dysphagia/dysphonia, please make NPO and consult SLP
Recommend PT/OT evaluation
Recommend obtaining TTE to rule out thrombus formation

Secondary stroke risk modification
- LDL at goal of less than 70. Can resume lovastatin 
- HgA1c at goal of less than 6.5%
- BP goal normotensive, please allow permissive hypertension until 8/20/20 5am (hold antihypertensives until then)

[] Heavy alcohol use


Binge Drinking Neutralizes Any Health Benefit of Alcoholic ...


[] Liver cirrhosis:
 CAUTION !!!!
 - bleeding
 - hypotension d/t low effective circulating volume 
  - IV lasix not massive. Slowly.. 

- Ascites management 
 Ascites is the accumulation of fluid within the peritoneal cavity. It is the most common complication of cirrhosis. The first step leading to fluid retention and ultimately ascites in patients with cirrhosis is the development of portal hypertension. Patients without portal hypertension do not develop ascites or edema. Those with ascites have several circulatory, vascular, functional, and biochemical abnormalities that contribute to the pathogenesis of fluid retention. (See "Pathogenesis of ascites in patients with cirrhosis".)
Ascites is typically treated with a combination of diuretics and sodium restriction, though some patients require repeated therapeutic paracenteses or TIPS placement. Among patients with refractory ascites or spontaneous bacterial peritonitis, the use of nonselective beta blockers may be associated with increased mortality [10,11]. This may occur because maintaining an adequate mean arterial blood pressure has been correlated with survival in patients with advanced cirrhosis. (See "Ascites in adults with cirrhosis: Initial therapy" and "Ascites in adults with cirrhosis: Diuretic-resistant ascites", section on 'Discontinuing beta blockers' and 'Decompensated cirrhosis' below and "Spontaneous bacterial peritonitis in adults: Treatment and prophylaxis", section on 'Discontinue nonselective beta blockers'.)


[] Liver cirrhosis
# How to adjust Antidepressants:
Anti -depressants: classification & mechanism of action
Start?
Maintenance?
Stop?

PSY...


# Post cardiac cath - brachial dissection or vascular complication:

 Rt. upper arm pain:

- 2/2 ?vascular complication post cardiac cath. or MSK
- VSS
- Unremarkable exam
- Labs: stable Hgb
- No emergent vascular evaluation indicated at this point 
- Doppler Upper arm. 
 - if there is any vascular emergency, then do level 1 CTA with consulting vascular surgery and interventional cardiology. 
- Frequent neurocheck and pulse check. 


# EKG lead placement 






                         4th ICS
                         (V3)
                         5th ICS & mid clavicle = "V4" -> ant. axillary "V5" -> mid. axillary "V6"  
Rt = Only Rt. same as V4R, V5R and V6R

V8= scapular tip -> lt. and rt. !(V7, V9) 




# woozing:

- 4hr after hemostasis
- 6hr bedrest after hemostasis

IMPRESSION:
1. Successful wide antral circumferential ablation for pulmonary vein isolation bilaterally. 
2. Ablation of additional foci at the ridge between anterior left superior pulmonary vein and the appendage. 
3. Ablation of additional foci  on the inferior portion the posterior wall by the left inferior pulmonary vein
2. Successful cavotricuspid isthmus ablation. 

PLAN:
1. Bed rest for 6 hrs after sheath pull => 1 hour. 
2. Colchicine for pericarditis prophylaxis
3. PPI for a month
4. Continue apixaban. 2.5mg tonight and then 5mg bid until followup with Dr. Ellenbogen.
- 1725PM. 

5. Continue home Tikosyn 500bid and metoprolol
6. Will monitor heart rate overnight to determine if we will put her diltiazem back on

# Tikosyn loading
[Initial]
-CrCl and QTc interval (or QT interval if heart rate is <60 beats/minute) must be determined prior to first dose. If QTc >440 msec (>500 msec in patients with ventricular conduction abnormalities), dofetilide is contraindicated.(NOT IN REALITY)  Adjust initial dosage in patients with estimated CrCl <60 mL/minute (see dosage adjustment in renal impairment). 
-Dofetilide may be initiated at lower doses than recommended based on physician discretion; however, if the lower dose is increased, the patient will require rehospitalization for 3 days.(5 total doses). 

- Calculate Cockgraft Cr Cl rather than GFR. (which is affected by weight) 
  To determine initial dose(Renal function and Baseline QTc)
CrCl >60 mL/minute: Initial: No dosage adjustment necessary.
CrCl 40 to 60 mL/minute: Initial: 250 mcg twice daily.
CrCl 20 to 39 mL/minute: Initial: 125 mcg twice daily.
CrCl <20 mL/minute: Use is contraindicated.

- If Ventricular Conduction Delay(VCD), then consider to adjust it before putting in BAZETTES.
 - Consider normal QRS as 100. If it's 140, then -40 in QT measurement before adjusting by HR. 

[Maintenance] 
- Stop criteria: >15% or >500
- K and Mg as >4 and Mg >2 ideally. If it's around 3.6 and/or 1.6 is ok??? 


# COVID-19 workup and management: in immunosuppressed subjects. 

# COVID-19 PNA: in the setting of immunosuppression
   unlikely overt bacterial infection per clinical sign nor rejection nor ACS(CAV)
- symptomatic with positive test result. 
- basic labs: CBC, CMP, PT/PTT, Troponin, BNP 
- infection labs: Blood culture, respiratory culture, respiratory pathogen, 
  legionella urinary Ag, CMV/EBV serology, IgG (+- fungal culture, fungitell = if it's indicated) 
- COVID labs: lymphocyte count(in CBC with differential), d-dimer, troponin, LDH, CK,  
  ferritin, CRP.
- CT chest with contrast
 - evaluate superimposed infection and the severity of disease. 
- oxygen as needed, currently >94% in room air. 

- if becomes hypoxic, then should consider Remdesivir and/or low dose dexamethasone and/or other investigational drug. 
- empirical antibiotics also will be on board when clinically it's indicated. 

- DVT ppx with heparin sq. 
- transplant ID consult in AM

ID Recommendations:
- If sats decline to 94% or lower/pt placed on O2, then will initiate Remdesivir and dexamethasone and discuss plasma consent.  (Pt aware and agreeable that she may qualify for available treatments if develops hypoxia but otherwise supportive care and IS mgmt alone for now)
- Send serum beta-d-glucan (Fungitell) and galactomannan (Platelia).  There is an association between COVID infection and Aspergillosis, and her infiltrate is likely all COVID related, but is somewhat nodular in appearance in some places.  Given lack of hypoxia, fever or dyspnea will hold on empiric azole therapy for now since this would also alter her tacrolimus.
- Continue pulse ox monitoring
- Monitor diff with CBC daily.  May need G-CSF if ANC < 1000
- DVT ppx as per hematology protocols
- Agree with holding MMF, and lightening tacro.
- Mycoplasma and Legionella studies neg, would not add atypical coverage at this time.


Please page COVID-19 Service this weekend if any acute changes or ready to start Remdesivir.  


"
Respiratory alkalosis: in the setting of COVID-19
- no current respiratory distress
- likely 2/2 mild pulmonary congestion and/or anxiety
- no hypoxia on RA concerning severe COVID-19
- COVID-19 related labs sent: LDH, Ferritin, D-dimer, CRP
- if there is any hypoxia, oxygen requirement, then consult ID and consider Remdesivir and/or dexamethasone. (not indicated for now) 
- s/p IV lasix once -> tachypnea improved 
"
# COVID-19
# COVID-19:
- Positive COVID-19 on 11/22. (It was negative on admission; 11/9)
- Clinically stable without any respiratory distress or desaturation. 
- VSS but fever(100.4)
- COVID labs: d-dimer, LDH, CK, ferritin, CRP.
- CT chest without contrast
- oxygen as needed, currently >94% in room air. 
- If becomes hypoxic, then should consider Remdesivir and/or low dose dexamethasone and/or other investigational drug. 
- Continue empirical antibiotics: vancomycin and zosyn. 
- DVT ppx with SCD(d/t subtherapeutic INR), Coumadin for now.
- Will consult ID in AM

# Blood gas
VBG vs ABG
(VBG -> ABG)
If oxygen saturation >93%: VBG = ABG
If Oxygen saturation <93%
 VBGpH + 0.001(93-venous oxygen saturation) = ABG pCO2  ===> kinda reliable. Pretty close.
 ex) 50% = +0.04 like 7.3 becomes 7.34

 VBGpCO2 -0.2(93-venous oxygen saturation) = ABG pCO2 ====> Not really. 
 ex) 50% = -8 like 48 becomes 40(huge!!! but not realiable <50%) 

 VBG: low pH, high CO2; but if if's normal = then consider ABG is normal. 
  • the 95% prediction interval of the bias for venous PCO was −10.7 mm Hg to +2.4 mm Hg. They note that in some cases the PvCO2 was lower than the PaCO2.

# Urinary retention:
- Q6HR bladder scan and straight cath(without balloon) 
-> failed
- Tamsulosin
- PREP: FOLEY Cathter set; Gloves X2; Gauze for holding it/better support.
- Need to place FOLEY Catheter. COUDE TIP at least 18 French FOLEY. (20 Fr. as well)
- Sterile prep, check balloon works(10cc total in), connect to the bag, penis point toward straight(not upright) after iodine prep.
- COUDE should point to umbilicus(up) and pass through it.
cf) TURP: resection of prostate = should work without any resistance.


# Pain control:
Opiate agents: Tramadol and pentazocine both offer similar pain relief during labor and are safe for the mother and the baby. The analgesic effect of pentazocine was sustained up till 4 h as compared to tramadol where the analgesic effect wears off early. However tramadol seems to shorten the overall duration of labour.



# GI bleeding: prep
 # IDA
-Recommend EGD and colonoscopy 6/11 w/ MAC. Clear liquid diet. NPO midnight except prep. Administer 4L of golytely and 10 mg PO dulcolax at 17:00 tonight and repeat dose with 4L of golytely and 10 mg PO dulcolax at 04:00 tomorrow.
-Agree with IV iron replacement

-Favor holding anticoagulation until procedure as may resect colonic polyps given Apixaban being held 72 hours prior to procedure with AKI.



# Sotalol loading:
ADVERSE = BRADYCARDIA or QTc prolongation

RN notified that pt. is bradycardic around 40s and some point it came down to 39 (and BP: 146/81) while he was awaken however he denies any weakness, dizziness, SOB, palpitation, n/v. His blood pressure has been stable. His baseline HR has been around 50s to 60s per patient unless he had episodes of afib with RVR which made his HR up to 169. He stopped taking his diltiazem 300mg on the last Thursday and today he got the 1st dose of 120mg Sotalol around 0253PM for recurrent afib/aflutter.

# Recurrent Afib/aflutter:
- currently sinus bradycardia (Sx, HR, BP, and QTc = KEY component.)
 - QTc: 425.
- Sotalol 120mg po q12hr. 1st dose given (determined by GFR)
- d/t significant bradycardia but asymptomatic
- will consider PM placement.
(NO RECENT CCB or BB)
- Decrease Sotalol to 80mg tonight. 

- d/w'd Dr. Shepard

* Medication / Disease related situation:
-Subjective, Objective 
(evaluate severity)
(investigating causes)
-Disease related q n a
-Medication(ask when was the last time, related adverse event, known side effect and so on)


# Pseudoaneurysm 
1-evaluation

Eval
Sx: Rt. groin pain, any numbness or weakness on peripheral area. 
VS
P/Ex: groin (hematoma, thrill, bruit, tenderness, oozing, demarcation/expanding?)
          peripheral both(palpable pulse vs. dopplerable pulses) 
Doppler evaluation(arterial > venous) 

Labs: Hgb -> possible retroperitoneal then CTA back/groin. 

Rec: 
- No surgical intervention at this time
- Recommend bilateral lower extremity arterial duplex on Friday
- Vascular surgery will reassess pending new duplex results

2-management: call vascular surgeon, thrombin injection as needed(>1cm)

# Cardiac catheterization related complication: bleeding
- Check mental status(subjective), pain, numbness, weakness of peripheral region.(b/l).
- Which medication was given ? 
   (Sx - Med) 

- Vital sign check frequently (Q15mins) and physical examination 
(1>hematoma = mark, 
 2> pulse check b/l from femoral, popliteal, DP, and PT, 
 3> bruit or thrill auscultation; 
  with neuro, cardiac examination as well.) 
=> EVALUATION SEVERITY
- Manual compression on hematoma, pseudoaneurysm or even bleeding
  check the site(Q30mins)
- Resuscitation(if consider bleeding) = FLUID resuscitation(NS bolus 500- 1000)
  and/or arrhythmia control(with Dopamine, Atropine in bradycardia)
=> URGENT MANAGEMENT

- CBC, lactate stat!!!!! then do the rest of work. 
   Labs to reverse anticoagulation effect such as PT, PTT, ACT 
  And CBC, Lactate, CMP, LDH, CPK(creatine phosphokinase) stat
  (possible muscle compression related) .
  And Type and Screen(if it's active bleeding or expanding hematoma, 2UNITS to give
  regardless its hgb level at that point)
- US(Doppler) to evaluate Hematoma or pseudoaneurysm(hemorrhage) or AVF.
- +- Echocardiography (r/o PERICARDIAL EFFUSION/hemopericardium from puncture) 
=> FURTHER EVALUATION OF SEVERITY(1)

- If Hgb drops so much, consider CTA !!! with Vascular surgery consult ready. 
  (ddx. retroperitoneal hematoma, arterial/venous active bleeding)
=> CAUSE? REASON WHY?!(SECOND WORKUP)


TX. Manual compression, Transfusion(pRBC or PCC4 or etc. ), Fluid

[EXAMPLE of hematoma approach - stable. ]
S> Pt. c/o soreness with compression however denies any other dizziness, numbness, weakness, pain on the lower leg, or SOB.  

O>
VS:    T  36.8 C  BP  104/63  HR  74  RR  18  SpO2  95%  Pain  5   Ht   172.0 cm(68")   Wt   103.1 kg   BMI   34.8   BSA   2.22 (09/02 11:16-09/03 03:00)
Focussed exam:
 Rt. Groin hematoma: size around 10cm. firm -> soft after compression. 
 No bruit nor thrill.
 Mild tenderness
 Strong palpable peripheral pulses
 Warm lower leg 

AP>
# Iatrogenic groin hematoma: 
- hemodynamically stable, no tachycardia
- arterial access
- manual compression for 20minutes -> stop expanding
- frequently check site, peripheral pulses
- stat CBC, type and screen
- doppler to evaluate hematoma/hemorrhage/AVF
- if hgb drops or turns hemodynamically unstable, then resuscitation(fluid, blood transfusion) and vascular surgery consult with CTA


WHAT - HOW - WHY

when,where,who = no needed....

# Pacemaker placement or upgrade related bleeding. 
- likely procedure related bleeding vs. hematoma
- VSS
- f/u H&H, type and screen sent
- CXR
- USG: chest soft tissue evaluation; however  if Hgb drops or becomes hemodynamically unstable, then consider immediate CTA. 
- conservative management for now. 
- EP evaluation in AM


# PNA
-CAP
-HCAP
-HAP
(Definition)

-How to Diagnose PNA (Sx/Lab and  Image)

- ID consult
- Further workup such as labs, bronchoscopy
 - Fungal culture
 - LDH for PCP
 - Mycoplasma
 - Mycobacteria(concerning like weight loss, night sweating, more than 2weeks)
  => airborne precaution, AFB.
 - Legionella Urinary Ag


-How to manage it per setting
 CAP
 HCAP
 HAP
 Immunocompromised(symptom = mild mild mild but CT shows something) 
 - ceftriaxone(1g IV Q12HR) + levaquin(750mg IV qday) for 7 days...






# Urinary Tract infection(UTI)
The Diagnosis of Urinary Tract infection in Young children (DUTY): a diagnostic prospective observational study to derive and validate a clinical algorithm for the diagnosis of urinary tract infection in children presenting to primary care with an acute illness.)\

UA:
we compared the number of squamous epithelial cells (using 10 or more squamous epithelial cells as a cut-point) in contaminated and uncontaminated samples
(REF: 

 Sx: Lower UTI
       Upper UTI

       AMS(without any other specific reason)

Tx. Oral= Cefdinir 300mg BID po 5-7days. 



# Aortic ulcer


# Toothache: Periodontitis
- treat with antibiotics?
- treat with swish and swallow
Meds
1) 0.12% oral chlorhexidine treatment q12hr and(swish and spit out)
2) Antibiotics: Augmentin X 14 days. 
Acute simple gingivitis rarely requires systemic antimicrobial therapy. Chlorhexidine 0.12% oral rinse can be used in most cases. Antibiotics are usually indicated for patients with rapidly advancing disease, severe pain, or an immunocompromising condition. Possible regimens include penicillin plus metronidazoleamoxicillin-clavulanate, or clindamycin (table 2). 
3) Severe disease (Parentral treatment) 




# Smoker:
Chantiks?? 

Transdermal patch: Topical: Note: Adjustment may be required during initial treatment (move to higher dose if experiencing withdrawal symptoms; lower dose if side effects are experienced).
Patients smoking >10 cigarettes/day: Begin with step 1 (21 mg/day) for 6 weeks, followed by step 2 (14 mg/day) for 2 weeks; finish with step 3 (7 mg/day) for 2 weeks
Patients smoking ≤10 cigarettes/day: Begin with step 2 (14 mg/day) for 6 weeks, followed by step 3 (7 mg/day) for 2 weeks



# bedbugs: contact precaution, epidemiology contacted.
 - skin care: topical hydrocortisone and/or oral antihistamine
 - clean belongings
- education: call experienced pest management and wash/dry with hot temp   (at least 50C)

# Lice: 
- contact precaution, epidemiology
- topical permethrin or oral ivermectin (for classic scabies)
- topical permethrin and oral ivermectin (for crusted scabies = old or immunocompromised)
 for 1-4 weeks. 
 if after 4weeks, then consider to change meds or check adherence. 
- Skin care(for nodule): topical hydrocortisone

# Tick Bite
-Tick found in clothing and on patient's left arm pit
-Removed by RN - no residual tick remanents left, area cleaned with alcohol
-Tick is possibly a male lone star vs deer tick
-Spoke with ID - treat prophylactically with Doxycycline 200mg PO once
-Monitor area for rash, warmth, swelling, and fevers

# Acute PE:
(Stable PE)
- heparin infusion
- workup for DVT


(Unstable PE)
- VS= unstable, indicated for tPA.
 (Ix.)
 (CTx.)

 - Stop heparin infusion
 - Start tPA(20mg IV bolus and 80mg infusion for the next 2 hours or just infuse 100mg for 2 hours)

(If there is bleeding on tPA)
 - STOP STOP STOP
 - cryoprecipitate 10 units + FFP 2 units
 - protamine sulfate 1mg : 100 units of heparin(if 2 hours later, then 0.5mg : 100 units; half dose)


# LHC radial hematoma:
- Oozing: re introduce TR band with protocol
- Hematoma: Manual compression(20 mins) 
 - 15mins/30mins/1hour/2hours monitor
 - 2 hours from hemostasis: resume heparin.
  (cf. general ablation or other cath protocol: 4 hours after hemostasis! with half dose of AC!)

- no ice pack
- manual compression and conservative management



# Hypertensive emergency:
- end organ damage
 - AKI, Encephalopathy, Vascular emergency(ACS, Stroke), and ADHF(pulmonary edema)
 - Goal: reduction 10-20% in 1 hour and rest of part during 23hours.(goal -25% in a day)
 - After 24hours: normalize to <130/90 (?)
[setting]
- HF:
 - Avoid BB, CCB and nor hydralazine
 - Mainly IV NTG !!! (+- Other vasodilator and Enalaprilat) or NTG patch
- Aortic dissection:

- ACS

- Encephalopathy

[medication onset - peak - duration]
Labetalol IV: onset quick - peak 3 hours - duration for 12 hours. 




# PM placement with compliacted Pneumothorax f/u:

Left sided pneumothorax
-s/p chest tube placement on 4/29
-repeat xray 4/30 with enlarging pneumo and chest tube retraction by 2 inches (may have occurred when patient went for xray);
-CXR with worsening pneumothorax on connecting the chest tube to water seal - now back to suction.

Tachy/brady syndrome s/p MDT VVI PM
-s/p Medtronic VVI PM implant; difficult procedure due to Left axillary venous access
-Device interrogation looks good
-Device site looks good
-continue chlorhexidine and mupirocin through 5/2
-Remove waterproof Aquacel dressing after 1 week.
-Avoid lifting left arm above the shoulder or lifting weight for 4 weeks.
-Follow up Dr. Koneru 6/5/20 CMH



# Renal patient with hyperglycemia

CrCl 10 to 50 mL/minute: Administer 75% of normal dose and monitor glucose closely.
CRRT:  Administer 75% of normal dose and monitor glucose closely; supplemental dose is not necessary

CrCl <10 mL/minute: Administer 50% of normal dose and monitor glucose closely.
HD= consider as CrCl<10mL: 50% of normal dose. Especially long acting should be lowered or initial dose should be lowered. Transitioning with lower dose => keep goal 180-200. Hard to manage but this is it! 

# Central line removal form:

     Pt. is hemodynamically stable but indicated to central line removal with highly suspicious of CRBSI. I explained patient regarding possible risks of procedure including air embolism, bleeding, hematoma, catheter fracture, dislodge of thrombus and benefit of controlling the source of infection. He agreed to get procedure done. Pt. was asymptomatic currently and stable VS. Neck was evaluated and positioned him to Trendelenburg position with educating him of Valsalva maneuver. Removed dressing and suture. After removal of old dressing, sterilized area with chlorhexidine and pulled central line with pt.'s Valsalva maneuver. Applied pressure on the site of IV insertion for 10 minutes and will keep him in the supine position for 30 minutes. No bleeding, hematoma, nor any distress currently.

Suspicious of CRBSI:
- Leukocytosis(>14K), fever(101F) but no altered mental status, stable VS but tachycardia related to cardiac transplant status.
- Central line placed about 2 weeks ago.
- Mild local sign of infection(redness but no discharge) without other source of infection identified.
- d/t given risk of immunosuppression with central line => highly suspicious of CRBSI
- empirical antibiotics started
- central line removed.
 - close monitor site, VS, and tip culture sent.
Tae shik Park, MD
Cardiology Hospitalist
p3490





# CRBSI: (IDSA ? recommendation?) 
- no other source of infection but definitely infected ? 
then suspect CRBSI 
- remove CATHETER ! with sepsis for sure.(or immunosuppressed! but VAD patient? = not right away
 1) significant => remove it asap
 2) not significant but evidence of infection without other source => remove it
 3) not significant with other source => leave it !



# OHT rejection treatmnet:
Acute antibody mediated cardiac allograft rejection.
Arthrogryposis multiplex congenita.
Status post orthotopic heart transplant.
Chronic immunosuppression.
Start on home dose of mycophenolate mofetil (1500 mg twice daily) and prednisone (5 mg twice daily).
Old tacrolimus.  Check tacrolimus trough level in the morning.
Will give 1 dose of IV methylprednisone 1000 mg.  Will consider given 2 more doses.
Continue with home dose of aspirin and losartan.
Continue with home dose of atorvastatin.
Start on home dose of dapsone, nystatin and valganciclovir.
Will get HLA class 1, HLA class 2 and (angiotensin type 1 receptor antibodies; only for antibody mediated rejection)

# Acute OHT rejection:(tx. per cellular vs Ab mediated and/or grade!) 
- RHC(10/1/2020) showed acute cellular rejection(ISHLT grade 1R), acute antibody mediated rejection(pAMR2) 
- VSS, Mild symptom of HF(orthopnea)
- Basic labs: CBC, CMP, PT/PTT, Troponin, BNP, Lactate
- OHT labs: Tacrolimus Tr
- TTE, Repeat RHC in 2 weeks or earlier
- Solumedrol 1g IV X3 and/or ATG(Anti-thymoglobulin therapy) 
- Consider to repeat plasmapheresis, IVIG ?
- Continue MMF 1500mg Q12hr, Tacrolimus(4/4 mg)



# OHT with possible stroke, supratherapeutic INR. 
IVF: 250cc bolus and f/u with 75cc/hr of NS

Assessment:
- dehydration
- hypovolemic hyponatremia
- diarrhea
- acute renal failure, likely multifactorial (dehydration, Bactrim)
- s/p LVAD
- chronic anticoagulation with coagulopathy, status post vitamin K 5 mg p.o. 04/30/2020
- elevated LDH, no evidence of pump thrombosis on log file analysis
Rule out outflow obstruction, although pump interrogation is unremarkable
Inflow appears patent on echo
Rule out non hemolysis source of LDH elevation
- slurred speech, possible TIA, symptoms resolved
- chronic polymicrobial driveline infection - currently no symptoms
 - DL infection: send blood culture + DL drainage culture for sure !!

Plan:
- COVID-19 screen negative
- stool for C diff
- chest x-ray
- blood cultures, wound cultures, urine cultures
- empiric coverage with vancomycin and Zosyn
- holding warfarin for now, restart if no surgical intervention needed
- start bivalirudin drip when INR < 3.0, PTT goal 80-100
- aspirin 81 mg daily when INR < 3
- LDL isoenzymes ordered
- hold hydralazine
- I independently reviewed echo images from today; my interpretation:  Small LV chamber size consistent with hypovolemia, no thrombus on inflow cannula, low diastolic flows, aortic valve persistently closed, RV cannot be well assessed, but does not appear severely dilated, although dysfunctional
- IV hydration with normal saline
- nephrology consult
- No LVAD speed change today.


- the rest is per the APP's note.


# OHT infection(respiratory) + rejection !!:
affect, cooperative

ASSESSMENT:
Status post heart transplantation, clincal rejection with new high MFI DSAs and systolic dysfunction by echo, concern for AMR
Chronic immunosuppression.
Abnormal CT Chest
Hypertension, controlled on Losartan


PLAN:
1. Start Solumedrol 1gm daily X 3 days. Resent HLAs and HLA AT1R
2. Continue Cellcept 1500mg BID and increase Prograf to 7mg BID. He admits to taking his Prograf late before his clinic draw Monday morning. He took 6mg late Sunday night before clinic monday morning last week.
3. Start prophylaxis as I anticipate he will be getting long steroid taper with treatment for AMR
4. Continue Vanc and Zosyn for abnormal CT Chest. Blood cultures sent and CMV PCR, Fungitell and Platelia sent as well. Will consult transplant ID for further recommendations.
5. Continue ASA, statin  - if he gets hypotensive again then we may need to drop his Losartan or hold altogether
6. Plan for RHC/EMBx on Monday. NPO after midnight.

7. Transfer to ICU for steroids today and careful monitoring.

===> Discharge plan:
1. Discharge: home today after plasmapheresis and IVIG completed
2. AMR Management:
  -Final session of plasmapheresis and IVIG today (4/29)
  -Repeat HLAs and AT1R drawn this AM (4/29) remain pending
  -Will undergo following OP treatment plan: 4 doses of Velcade and 2 doses Eculizumab
  -OP treatment will begin on 5/1/2020
  -Continue Losartan 25 mg once daily for AT1R antibodies
3. Immunosuppression:
  -Continue Envarsus at 10mg PO qd
  -Continue trending daily tac levels, tac 11.4 this AM (4/28)
  -Continue MMF 1500mg PO BID
  -Continue Prednisone 5mg PO BID
4. Immunoprophylaxis
  -Continue Dapsone 100mg PO qd - will need 6 month course
  -Continue Nystatin 5mL swish and swallow
  -Continue Valcyte 900mg PO bedtime - will need 3 month course
   -Continue Penicillin V potassium 500mg PO bid
5. CAV Prophylaxis:
  -Continue ASA 81mg PO qd
  -Continue Lipitor 10mg PO qd
6. Electrolyte Management:
  -Continue Mag oxide 800mg PO qd
  -Encourage low-potassium diet given recent hyperkalemia
   -K 4.7 this AM (4/29)
7. PSY Management:
  -Psych and addiction medicine consults completed
  -Pt confirms he would like to follow-up with psychiatry as OP
  -Provided pt with OP PSY contact info as he is deciding between establishing therapy closer to home vs. VCU
8. Discharge Logistics and Follow-Up Items:
  -Pt drove himself to the hospital and will transport himself home- he is at his baseline mobility and on no sedating meds
  -Will return to OP clinic on Friday (5/1) for Velcade and Eculizumab at 8AM on Gateway 7
   -On 5/1, pt will be receiving Velcade dose 2 of 4 and Eculizumab dose 1 of 2
   -Pt will receive Velcade weekly until completing his 4th dose and will receive his Eculizumab doses two weeks apart
   -Repeat Tac level, BMP, Mag, CBC and Hepatic panel orders placed for Friday 5/1/2020
   -CC confirmed HH set up to monitor trialysis line (Personal Touch Home Health Agency)
  -Remaining Vaccination Schedule: Meningoccocal Conjugate (Menveo) 6/25/2020, Meningococcal Group B 5/25/2020

# Acute Diarrhea: in light of OHT status. 
- less likely thyroid disease, food poisoning but likely infectious? d/t immunocompromised status
  or colchicine related. 
- unlikely pancreatitis or hepatobiliary disease
- Labs: TSH; Infection workup: Stool study(C. diff, WBC, RBC, Stool pathogen and parasite workup including Cyclospora, Giardia, Cryptospordium) d/t cat bite and risk of zoonosis.
  ;Transplant patient: CMV, EBV and IVIG level
- no antibiotics indicated at this point however Ceftriaxone started for the other indication as above
- contact plus precaution
- IVF for now


# Acute Rejection in cardiac transplant(less than 1 year):
46yo male s/p OHT (10/2019) presenting with shortness of breath, volume overload, potential rejection.
1. OHT, Possible cardiac allograft rejection
-significant decrease in BiV systolic function(Bedside ECHO - really important!)

Plan
1. For possible rejection:
-RHC w/biopsy in the AM
-Start methylprednisolone 1 g x 3 doses (4/29-5/1)
-HLA labs: class I, class II, and AT1R ordered 4/29
2. Start Dobutamine 3 mcg/kg/min
3. Continue Lasix 40 mg daily - may increase to bid if inadequate urine output
4. Hold Apixaban for procedure; start Heparin gtt(rejection related thrombosis?)
5. Continue immunosuppression:
-Tacrolimus 3 mg in AM, 2 mg in PM; will check level with AM labs
-MMF 1500 mg bid
-Hold Prednisone until 5/2(d.t solumedrol) 
6. Continue immunoprophylaxis, CAV prophylaxis
New New Oral Anticoagulants 2014
# Warfarin reversal 
 - INR >1.5 s/p Vitamin K 2.5mg 
 - Vital, H&H and INR(after 12 hours. )
Onset of action: Increased coagulation factors: Oral: 6 to 10 hours; IV: 1 to 2 hours
(f/u 12 hours vs. 6 hours, respectively. Warfarin has nearly 100 percent oral bioavailability = oral = IV dosing.)
Peak effect: INR values return to normal: Oral: 24 hours; IV: 12 hours 

# Warfarin reversal with supratherapeutic INR and BLEEDING. 
- Severity(Evaluation and Management): what, how
 - check symptom
 - vital sign: tachycardia and hypotension(significant! emergency situation = ICU)
 - labs: PT/INR, PTT, CBC stat.
 = assessment.
 - IVF(1L), labs: CBC, Hgb stat, BMP stat(for possible other cause or organ damage)
 - type and screen for emergent blood transfusion.
 = emergent management.

- Cause(Warfarin -> Reversal; investigate where it is?!!?): why
 - reversal of INR= IV 10mg phytonadione.INR Q6HR (or IV 5 - 10mg per severity or INR)
 -  FFP 2units vs. 4 units
    or   4F PCC 2000 units and/or additional INR q15mins. 
 - Image workup: CTA basic(if kidney function problem => IR or GI or Uro. contact) or  
   USG/dry CT(initial can be this one).

  ; Vitamin K 10mg IV(for 1 hour, after 24hours, if it's still high, then give next dose!)
  ; FFP(10-15cc/kg IV; recheck INR q2HR and repeat as needed. => in general 2 units for moderate  
     or 4 units for severe at once.  )
    or 4F PCC(KCENTRA; TOC; We suggest a 4-factor prothrombin complex concentrate (PCC; INR 2-4; 25units/kg, 4-6; 35units, >6; 50units. OR 2000units + 50units*n)
    (table 2) rather than a 3-factor PCC and/or Fresh Frozen Plasma (FFP))
     or 3F PCC.
***
(NO BLEEDING and INR  5-8.9 = 2.5mg phytonadione oral; 9.0 = 2.5 or 5mg phytonadione oral or IV 1-2.5mg by slow. Recheck INR Q12hours and repeat if it's necessary )




Guideline recommendations for management of warfarin-associated bleeding and/or high INR
Clinical setting2018 ASH guideline2012 ACCP guideline
  • Serious or life-threatening bleeding
  • Any INR
  • 4-factor PCC
  • Vitamin K (intravenous)
  • Hold warfarin
  • 4-factor PCC*
  • Vitamin K (intravenous)
  • Hold warfarin
  • No bleeding
  • INR >10
(No recommendations given)
  • Vitamin K (oral)
  • Hold warfarin
  • No bleeding
  • INR 4.5 to 10
  • Hold warfarin
  • No vitamin K
  • Hold warfarin
  • Vitamin K (low dose, oral) is optional

A. If 4-factor prothrombin complex concentrate (4F PCC) is available (preferred approach):
1. Give 4F PCC(2,7,9,10 and C&S) * 2000 units IV over 10 minutes. Check INR 15 minutes after completion of the infusion. If INR is not ≤1.5, give additional 4F PCC (500 units repeatedly!!! refer to topic or drug reference for details).
2. Give vitamin K 10 mg IV over 10 to 20 minutes.
B. If 3-factor prothrombin complex concentrate (3F PCC) is available but 4F PCC is not available:
1. Give 3F PCC(2, 9, 10 without 7)* 2000 units IV over 10 minutes. Check INR 15 minutes after completion of the infusion. If INR is not ≤1.5, give additional 3F PCC (refer to topic or drug reference for details).
2. Give Factor VIIa 20 mcg/kg IV OR give FFP 2 units IV by rapid infusion. Factor VIIa may be preferred if volume overload is a concern.
3. Give vitamin K 10 mg IV over 10 to 20 minutes.
C. If neither 3F PCC nor 4F PCC is available:
1. Give FFP(all factors, fibrinogen, C&S, everything) 2 units IV by rapid infusion. Check INR 15 minutes after completion of infusion. If INR ≥1.5, administer 2 additional units of FFP IV rapid infusion. Repeat process until INR ≤1.5. May wish to administer loop diuretic between FFP infusions if volume overload is a concern.
2. Give vitamin K 10 mg IV over 10 to 20 minutes.

cf) in DOAC with bleeding = can be treated with 4F PCC(2000 unit once!) 

# Warfarin maintenance adjustment protocol(conservative method - avoid unnecessary bleeding)

Warfarin PK: 
Onset of action: Initial effect on INR 24-72hours. BUT Full therapeutic effect generally seen between 5 and 7 days. Prothrombin (factor II), which has a half-life of 72 hours.(no addtional synthesis however stay longer!!! than Protein C&S which has short half-life = disappeared really quick(anti-coagulant; 8hours), it can paradoxically increase the coagulation tendency leading to massive thrombosis with skin necrosis and gangrene of limbs. 

1) initiation: 5mg and 72hours rule!(1.5=increase, 1.9 continue, 2 decrease,  2.5 hold)

 5mg -> check INR in 2-3days(48-72hours rule; supratherapeutic needs to be checked in 1-2days)
              <1.5 = 7.5mg daily
              <1.9 = 5mg daily
              2 = 2.5mg daily

              >2.5 = hold and recheck in a next day. -> recheck in next day.
          -> generally recheck in 2-3days after adjustment.(for adjusting protocol 72hours.)
              <1.5 = 10mg
              <1.9 = 7.5mg
              2 = 5mg
              >3 = hold and recheck in a next day.(supratherapeutic - will test in a day exceptional)

** Oxford protocol
 5mg for 3 days
 <1.5 = 10mg
 1.5-2 = 5mg
 2-2.5 = 3mg
 2.5-3 = 1mg
 >3 = hold
 recheck in a day(day #4)
 <1.5 = 10mg
 1.5-2 =5-7.5
 2-2.5 =5mg
 2.5-3=3mg
 3-3.5 =2mg
 >4 = 0mg
 recheck in a day(day #5..)


2) f/u (after initiation)
    every 2-3days until INR within therapeutic range on 2 consecutive INR
    (2 times = 3days X2 = almost a week.)
    Then every week until within therapeutic range on 2 consecutive INR
    (2 times = 1weeks X2 = almost 2 weeks)
    Then two weeks until...
    (2 times...)
    Then four weeks until
    Then monthly. (generally 1 month => if it's stable for 6 months then 2 months maximum)

3) maintenance f/u and frequency
    Change in diet, medication such as transient effect.
    -> recheck in 3-5 days.(72hours rule!)

    # Adjustment by 5-10% (regularly 5-10% in a week dosage change =
    5% = 0.5 change in INR (if INR <1.9 = 5%)
    10% = 1 change in INR (if INR <1.6 = 10%)
    20% = 2 change in INR (if INR <1.2 = 20%)
    booster dose can be given 1.5 times higher dose once!(if it's subtheerapeutic)
    hold 1 dose can be done once if it's <4.5(if it's supratherapeutic)
    -> recheck in 1-2weeks.
     
    * exceptional range(considered to be transient !!!)
    INR > 4.5 - 10 without bleeding = hold 2 doses and/or Vit K(oral 1mg) can be given.
    recheck in 3-5days
    INR >10 without bleeding = hold 2 doses and Vit K(oral 2.5mg) can be given and
    recheck INR daily until it's therapeutic. Then resumed at a lower dose(20% for sure).

TIPS>
 If INR <0.5 range out of target and previously stable = continue and recheck in 1-2weeks.
 Otherwise need to adjust with omitting/boosting and adjustment.
 Interaction
 a) Amiodarone: day 7 of amio = decrease 25% weekly dose
                           day 14 of amio = decrease another 25% weekly dose
                          (target: 50% reduction in weekly warfarin dose after 2weeks of interaction)
                          -> check INR after 7days, 14days and 21days. = weekly like maintenance adjustment
 b) fluconazole, metronidazole, bactrim = day 1 of interaction = decreased 30% weekly dose
                          -> check INR "3"-5 days (transient one rule)
 c) all other interaction -> check INR "3"-5 days and adjust as indicated.




# Periprocedural AC(on holding vs. Bridging):
- DVT s/p IVC, on DOAC
referred for RHC and Biopsy as part of his OHT surveillance
 -> Hold 2 days of Apixaban(3 doses) prior to RHC with EMB

- LHC
 -> hold 1 day of Apixaban prior to LHC. 
 -> can be resumed "full dose" after 4-6 hours of hemostasis. 

 cf) EP ablation 
 -> hold 1 day of Apixaban
 -> can be resumed after 4-6 hours of hemostasis with "half dose" ! 



# Hypomagenesemia:
- <1.9
- 1g / 30minutes
- 2g / 1 hour
- will increase 0.2 (1g:0.1; 2g:0.2
 - e.g. 0.8 - 1 : needs 6 g = that means. total 3 doses of 2g needed in 1. 
- 2 grams of IV magnesium sulfate increased serum levels by a paltry median of 0.2 mg/dL.

Hyperglycemia(uncontrolled DM) 
1. Type 2 diabetes mellitus
2. Hyperglycemia
Chronic, uncontrolled based on A1c 12.9% on admission
Home regimen: 70/30 insulin BID 50-100 unit(s) based on BG
Modifying factors: obesity, insulin resistance, lack of insurance, dietary indiscretions

Overnight glucose stable but elevated after dinner >200 mg/dL
CABG planned for 4/28, would like improvement in glucose pre-op

Reviewed blood sugar readings and insulin doses; calculated insulin need to make changes in his regimen:
Recommendations:
-INCREASE glargine to 70 unit(s) q24 hrs, patient will receive an extra 10 units of glargine this morning
Tomorrow recommend nursing split the injection into 2 doses given at the same time to ensure absorption (ex 30 units + 40 units as 2 SQ injections)
-INCREAE lispro to 22 unit(s) AC TID - HOLD if not eating
If eating a lower carb meal <30 gm CHO then only give Lispro 15 units
-Monitor BG AC TID, HS and 2 AM
-Correction scale with insulin lispro 3 unit(s) per each 50 above 150 mg/dl AC TID
3 unit if glucose 150-199,
6 units if glucose 200-249,
9 units if glucose 250-299,
12 units if glucose 300-349,
15 units if glucose >350.

If glucose at bedtime tonight is above 200 mg/dL, then recommend starting insulin infusion per general hyperglycemia protocol. Continue prandial lispro. Discontinue glargine and correction lispro. Nursing to see addendum in insulin drip nomogram for patient eating, please administer SQ lispro at time of meal and do not increase the insulin drip rate for 4 hours, may always reduce the infusion rate if necessary based on glucose

-Please do not administer correction scale at bedtime
-Ensure hypoglycemia protocol is in place
-CDE consulted for DM education

-Carbohydrate controlled diet

RV STEMI
- EKG(V1 and V4R, V5R, V6R) with two of  V4R/V5R/V6R leads being ST elevated. 
- No preload decrease with NTG d/t worsening Preload(in the setting of RV shock = almost no preload..) 
- IVF? 

# Hypoglycemia

- in DM

- without DM
 - adrenal insufficiency? 
 - other DDx? 
# Periprocedural glucose control
(Evaluation-severity) 
- Chronic, uncontrolled based on A1c 12.9% on admission
- Home regimen: 70/30 insulin BID 50-100 unit(s) based on BG
- Modifying factors: obesity, insulin resistance, lack of insurance, dietary indiscretions
(Long acting and short acting scheduled insulin)
-Goal BG 140-180 mg/dl (inpatient glucose goal)
- Given BG trend overnight would recommend to increase long acting insulin
  -INCREASE glargine from 50 units to 60 unit(s) q24 hrs (20% increased)
  -Continue lispro 18 unit(s) AC TID - HOLD if not eating
  -Monitor BG AC TID, HS and 2 AM(key tip!) 
(ISS)
-Correction scale with insulin lispro 3 unit(s) per each 50 above 150 mg/dl AC TID
 (3units to decrease 50)
3 unit if glucose 150-199,
6 units if glucose 200-249,
9 units if glucose 250-299,
12 units if glucose 300-349,
15 units if glucose >350.
(Routinely)
-Please do not administer correction scale at bedtime
-Ensure hypoglycemia protocol is in place
-DM education
-Carbohydrate controlled diet
(Comorbidity)
-T2DM and HLD: Goal LDL < 55 mg/dl. On atorvastatin 80 mg/d
(Periprocedural)
-Plan for CABG on 4/28 -- patient would require euglycemia prior to surgery,
 if by 4/27 BG remains >200 mg/dl would have low threshold to start insulin drip to achieve euglycemic prior to surgery.


 Intertrigo



# Chest pain: approach

# Atypical CP: 
likely 2/2 SVT and/or NSTEMI (likely type II but abnormal EKG might reflect underlying disease)
less likely aortic dissection, PE, GI
- Aortic Dissection Detection Risk score(ADD-RS): 1, will get d-dimer 
 - BP both arms. 
- Wells score for PE: 0
- serial troponin and EKG 
 - trending down troponin
- if d-dimer is elevated >500ng/mL, then will get CTA asap. 
- basic labs: CBC, CMP, PT/PTT, troponin, BNP
- CXR, TTE
- Consider CTA if it's indicated. 
- ASA, Ticagrelor loading, heparin infusion, atorvastatin were initiated. 
- d/t bradycardia, b-blocker was held. 

# SVT: 
- likely autonomic drive?
- s/p adenosine 6mg, 12mg
- currently NSR
- likely 2/2 ischemic drive. 

Aortic dissection
: Typical history = ? 


Mr. Morris is a 47 y/o M with PMH of HTN, HFpEF (EF 70%), OSA (wears CPAP at night), CVA in 2016 (no residuals), and CKD Stage IV who presented to the ED on 4/15/2020 with complaints of chest pain. Per the patient he was moving heavy furniture prior to arrival when he had acute onset of chest pain, states it has been happening intermittently over the past few months but was significantly worse this time. He endorsed SOB but denied diaphoresis, n/v, or palpitations. EKG showed acute MI with depression in Leads 2 and 3 and elevation in V2, given ASA in EMS. He endorses that he has missed several doses of his medications because he forgets to take them.


He was initially admitted to the stepdown unit for ACS work-up. Cardiac enzymes were negative overnight. ECHO completed 4/16 was concerning for dissection, CTA completed which revealed Type A dissection which extends to the left common iliac artery. CT Surgery was consulted and he was posted SN 2 for the OR. He was brought to CSICU for blood pressure management and monitoring until OR.

vascular:

 47 YO AAM with PMH HTN, OSA, HFpEF (55%), CVA in 2016 ( no residual deficits) and CKD IV (not on dialysis, producing urine) presented to the ED 04/15/2020 with chest pain. Pt with EKG findings of acute MI on admission and underwent echo that demonstrated possible dissection followed by confirmatory CTA. Vascular surgery consulted for Type A aortic dissection. Dissection extends to the left common iliac. Pt with no evidence of abdominal or lower extremity malperfusion.

No acute vascular intervention warranted, recommend CT surgery consult for repair of thoracic arch
Recommend admission to ICU for BP control systolic <120 HR < 70 
Vascular will continue to follow

[CT surgery] 
Surgical/Procedure Summary:

Plan for Type A 


# Pregnancy and AHDF




# Pulmonary catheter
- way of placement and what to detect?
- indication?
- management? 

# CDI: watery diarrhea >3/day.
[Classification]
- Risk(predisposition): abx. within 3 months(esp. Pc, Cef, LQ, and Clindamycin).
 - Suspicion: elderly, elevated WBC, abdominal pain and fever
- initial encounter vs. recurrent
- nonsevere vs severe(WBC>15000 and/or Cr>1.5) vs fulminant(hypotension, toxic megacolon, ileus)
[Dx]
- labs: CBC, CMP, Stool(RBC, WBC, Cx. and C.Diff)
- images: (not routinely) unless concerning complication such as perforation, ileus, toxic megacolon. KUB -> CT
  cf. Colonoscopy: for ileus, without diarrhea to see intracolonic inflammation(pseudomembrane)
[Tx]
- stop unnecessary inciting antibiotics.
- start to treat for 10 days of course
 - non severe: oral vancomycin or fidaxomicin (same efficacy) >> metronidazole oral (lower)
 - severe: oral vancomycin or fidaxomicin >> metronidazole
 - fulminant: oral vancomycin + IV metronodazole.
- Recurrence(>more than 2 weeks from completion of therapy)
 - if vanc was used => fidaxomicin or long term vanc(12weeks)
 - if fidaxomicin or metronidazole => vanc for 10 days
 - 2nd recurrence: as above or Vanc + followed by Rifaximin 400mg 3 times for 20days
                                or FMT.

# Anemia
- Reticount
- Iron testing
- Vitamin B12, Folate, 

# IDA
- Iron saturation low
- Reeticulocyte count

IV iron regimen and F/U test

PO iron regimen and F/U test

DDx. Thalassemia
 Normal; RBC count(5)  X 3 = Hgb(15) 
 But Thalassemia; RBC count high but Hgb low (false positive anemia) 
 and Iron test

# Fever
- DDx. DVT/PE(d-dimer) or other Deep tissue inflammation such as pericarditis(hsCRP) 


- Infection workup and empirical treatment 


# HCAP vs CAP vs HAP
- definition

- CAP:

# COVID-19(PUI vs. Confirmed case):
- Risk factors
 1) contact to COVID patient(within 14 days from sx. onset
     ; 14 days ago COVID - Sx. for now = still in risk; even general incubation in 3-5 days) 
 2) travel outside of country(within 14 days from sx. onset.) and (-) FLU
 -----------------------------------------------------------------------> hx of exposure
 3) SNF/LTAC; and (-) FLU and (-) RPP and no alternative Dx. 
 4) Old(>65) and chronic ds.(and/or immunosuppressed); and (-) FLU or (-) RPP and no alternative Dx. 
 -----------------------------------------------------------------------> community based weak population
- Lower respiratory symptom: SOB, Cough(and/or Fever)  <-> cf. URI: rhinorrhea(nasal), sore throat
 - mild vs. moderate/severe 
- Basic labs: CBC, CMP, Troponin, BNP, TSH(in CHF labs) 
- PUI labs:
  - RPP(including FLU), COVID-19, sputum culture
  - blood culture
  - Images(CXR -> consider CT scan per severity) 

- Ix. to send COVID 19 test with NPS(RiskCXR, SOB, flu, RPP, no alternative dx. )
 - mild resp. + risk factor; CXR(could be negative) = flu/RPP; send op. COVID-19  => home and self quarantine
 - mod/severe resp.; CXR(b/l infiltration) = (-)flu OR (+) RPP but hypoxia(resting SOB);without alternative diagnosis
   call command center to guide. 

- Precaution: Airborne precaution if there is Aerosol-Generating-Procedure such as CPAP/BIPAP, intubation, suction, high frequency oscillatory ventilation, tracheostomy, chest PT, nebulizer treatment, sputum induction, bronchoscopy. 
(tube, bronco and even CPAP, Duobneb treatment

*SOB/hypoxia -> regardless RISK(community possible enough) -> test negative and CXR infiltration -> Command center
*cough and RISK -> test negative and/or CXR infiltration -> still OP. COVID-19(Command center as needed) 
*PPE regular: yellow(IP, hallway, and commute) < PPE contact(flu positive or PUI): new mask+gown
  < PPE airborne(suction, intubation, etc.): N95 for sure. @ VCU. 

# High flow oxygen (Liter, Rate) vs. High frequency oscillatory ventilation



# Endocarditis: 
- Type: native valve/prosthetic valve 
- Hx:
  risk factors: history of IE/congenital/valvular heart disease
  predisposing factors: IVDU, indwelling IV line, dental/surgical procedure, immunosuppression
- P/Ex: 
  vascular phenomana or immunologic phenomena: 
  septic pulmonary infarct, mycotic aneurysm, ICH, conjunctival hemorrhage, Janeway lesion(non-tender, small  
  erythematous/haemorrhagic macular, papular or nodular lesions on the palms or soles);
  GN, Osler nodes(painful, red, raised lesions found on the hands and feet), Roth spots(hemorrhage in the retina with a white 
  center), RF * Janeway(non tender red) vs. Osler(tender raised red) 
 - NEURO(EYE), DENTAL, PALM AND SOLES. 
- basic workup: CBC, CMP, PT/PTT, Troponin, BNP
- other endocarditis labs: Blood cultures X3, Rheumatoid factor, UA.(minor criteria)
  ESR, CRP, 
  C3, C4, CH50 in subacute endocarditis. => not necessary though. 
  (hyperglobulin, cryoglobulin, IgG, hypocomplementemia, false positive syphilis test) =>(not necessary)
- CXR, TTE(consider TEE)
- EKG: evaluation for conducting system
- DUKE Criteria: 2 maj or 5 min (or 1+3) 
- No surgical indication(early indication: valvular dysfunction or HF or 1cm mass) then consider CT surgery consult. 
 - device infection: remove it. continue Abx for 7-14days after removal. 72hours of negative culture for reimplant. 
 - LVAD: IV -> PO(chronic suppression) 

- Medical management 
 - empirical antibiotics: Vancomycin.(trough 15-20).  (if unstable, then add Cefepime
 - antithrombotics: no benefit unless there is other indication.
    But if there is MS with Afib, then start AC. 
    But if there is ICH/Ischemic stroke likely 2/2 septic emboli, then stop AC/ASA.
    antithrombotics: held ASA d/t increased risk of hemorrhagic stroke.
 - taylored antibiotics (per ID, prosthetic valve has different combination regimen for SA or enterococcus). 

- prophylaxis: Ix(h/o IE, congenital heart disease + a(residual), MV ring, prosthetic valve, OHT with h/o valvulopathy)
  + respiratory procedure with biopsy/incision or dental procedure. (mainly)
  - method: amoxicilin 2g (30mins prior) or clindamycin 600mg or azithromycin 500mg. (iv cefazolin as well).

- Unusual bacteria: False-positive culture results occasionally occur. Organisms for which it can be difficult to distinguish between pathogenicity and contamination include Cutibacterium (formerly Propionibacterium) acnes
Gram positive rods: Corynebacterium species, Bacillus species, 
Coagulase-negative staphylococci. => repeat culture and start VANCOMYCIN ? 

- Culture negative IE(7days negative): empirical combination therapy such as Vancomycin+Cefepime(Acute) or Vancomycin+Augmentin(subacute) or Vancomycin + Ceftriaxone etc. BUT mainly consult ID at this point for sure.

Infective endocarditis

#  Empirical antibiotics and target coverage
(https://viewer.microguide.global/secure/8b046be8-fccc-43e6-93f7-10b4928a7548)

Ds-Empirical Abx.-Coverage.

# Sepsis / Septic shock
- SIRS criteria: HR>90, RR>20, WBC>12 or <4 or>10% band, Fever >100.4
  + BP criteria(from qSOFA: AMS, RR>22, sBP<100) 
  Septic shock: Sepsis + sBP<90 or MAP<70; require pressors(NE, Vasopressin, and EPI)
- Lactate(>4; severe sepsis: UOP <0.5cc/kg/hr; ALI; AKI(Cr>2); AMS; Bil>2; Pls<100K; etc.) 

- Basic labs: CBC, CMP, PT/PTT, Troponin
- Infection workup: Blood culture X2(one pph, one from vascular access device unless within 48hours - no risk) 
  UA/Urine Culture; Sputum/respiratory culture; wound culture; stool workup = per clinical scenario.
- CXR
  Possible CT abd/pelvis(abdominal workup)
 - Sources control(m/i): identification and appropriate antibiotics(key) 
- REMOVE vascular access if it's suspected. (however can wait if it's not clear at this point clinically) cf. PICC part
- IVF

- empirical antibiotics: per suspected source(SA, Str = can be anywhere. less likely in GI, GU though but possible.
* HAP/UNKNOWN >>> ABD >>> BLOOD STREAM >>> UTI

 1. UTI: CEFEpime(or ZOSYN) (Pc. allergy: Levofloxacin and Gentamicin=nephrotoxic) = only G(-) coverage
 2. central line: VANC and CEFEpime(or ZOSYN).= MRSA, G(+) and G(-) Coverage
 3. abdominal: VANC and ZOSYN. (Pc allergy: VANC and Cipro and Metronidazole and Gentamicin=nephrotoxic) =
    MRSA, G(+) and G(-) both coverage why? enterococcus faecium(is not covered by ZOSYN, covered by VANC!, surely 
    covered by levaquin)
    - @ ICU: VANC and ZOSYN and Gentamicin (or micafungin 100mg iv q24hr)    
    - diverticulitis: ZOSYN will be good enough. = cover G(-) and Anaerobe coverage.           
 4. HAP~HCAP(3mo.): VANC and ZOSYN and LEVAQ
   - CAP:
 5- unknown:VANC and ZOSYN and LEVAQ

* In my approach: Pc allergy => Try meropenem
* LEVAQ: super coverage even including G(+; MRSA), G(-; Pseudomonas), atypicals

# Empirical antibiotics coverage(Type, disease, target) 

# Blood stream infection(CLABSI/endocarditis): 
 - CLABSI: VANC+CEFEPime. 
 - Endocarditis: VANC(cover more than 80% of bacterias which are G(+) in endocarditis). cf) HACEK, G(-) is possible for 
                         + CEFEpime(in unstable patient, such as sepsis!!) 

# Skin/Soft/Bone: purulent or non purulent and/or systemic involvement !! 
- Non purulent cellulitis: VANC+ZOSYN(severe= double coverage even broader stronger! )
  (cellulitis, erysipelas; more superficial, superficial lymphatics involvement=milder disease upto moderate..)
                                         Cefazolin IV(moderate, mild)
- purulent cellulitis with (abscess or drainage): VANC(Severe)
                                                    Bactrim DS or Doxycycline or Clindamycin (Moderate=systemic sign)
                                                    No abx(abscess <5cm & no systemic symptom)
- Necrotizing: VANC+ZOSYN+Clindamycin(double coverage and strong cover for strep.) 

- osteomyelitis

# Respiratory
-bronchitis
-pneumonia
 - CAP
 - HCAP
 - HAP

# GI
- enterocolitis
- ischemic colitis
- diverticulitis
- hepatic abscess?

# GU(UTI); symptom= dysuria, frequency, suprapubic pain, urgency, and hematuria
generalized symptom= fever, chills, rigors, fatigue, malaise = need to check.

- cystitis
- pyelonephritis: n/v .. 
APN= flank pain, costovertebral angle tenderness, and nausea/vomiting 

# CNS
- meningitis
- encephalitis



# Myocarditis - mimicking like CAD(Takotsubo), ADHF, or Arrhythmia. 
- R/O ACS: serial troponin and EKG
- Acute(<3mo.) vs Chronic(>3mo.)
- Clinical suspected (sx=CP, SOB, Fatigue, palpitation, syncope, cardiogenic shock) 
  Diagnostic criteria (EKG: 1-3AV block, BBB, ST, Q, TWI, afib, VT; Troponin; Echo =regional/diffuse dysf.)
  AND no other cause(such as CAD>50%, Valvular disease, CHD, hyperthyoridism, sarcoidosis) 
  = 1 clinical + 1 diagnostic = 2 diagnostic
  Other supportive symptom = fever(in 1mo.), toxic agent, and autoimmune disease. 

- Labs: CBC, CMP, PT/PTT, Troponin I, BNP, ESR, hsCRP(vs. CRP), TSH(hyperthyroidism can mimic)
- CXR, TTE(R/O Takotsubo) and/or CMR (+-CAG)
- Avoid NSAIDS(including ASA), Exercise(abstain from for 6 mo. and reeval), and EtOH. 
- Manage ADHF, Arrhythmia as usual 

Fulminant myocarditis(shock status): 
 high dose steroids(high dose = more than 30mg prednisone a day; cf. less than 7.5 = low) 
 (reference. AHA scientific statement from Dr. Kociol et al.) 
  - 1g methyl prednisolone for 3 days and Prednisone 60mg with 10-mg/kg taper. (with 5-7.5mg maintenance) 
  - if hypotensive, consider NE than dopamine (esp. AMI shock, NE is preferred) or mechanical support. 
  - CAG +- EMB

[ ] how to r/o or r/i with pericarditis with myocarditis

# myopericarditis: treat as myocarditis but Colchicine can be useful for pericarditis. (But avoid ASA nor NSAIDS.)

# Acute pericarditis: Colchicine or NSAIDs(including ASA) 

# Chronic pericarditis

# Recurrent pericarditis